AP2374A - Isoxazoline derivative and novel process for its preparation. - Google Patents

Isoxazoline derivative and novel process for its preparation.

Info

Publication number
AP2374A
AP2374A AP2007004103A AP2007004103A AP2374A AP 2374 A AP2374 A AP 2374A AP 2007004103 A AP2007004103 A AP 2007004103A AP 2007004103 A AP2007004103 A AP 2007004103A AP 2374 A AP2374 A AP 2374A
Authority
AP
ARIPO
Prior art keywords
preparation
novel process
isoxazoline derivative
isoxazoline
derivative
Prior art date
Application number
AP2007004103A
Other languages
English (en)
Inventor
Tae Ho Heo
Jae-Hoon Lee
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Application granted granted Critical
Publication of AP2374A publication Critical patent/AP2374A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AP2007004103A 2005-02-26 2006-02-21 Isoxazoline derivative and novel process for its preparation. AP2374A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20050016203 2005-02-26

Publications (1)

Publication Number Publication Date
AP2374A true AP2374A (en) 2012-03-07

Family

ID=36927605

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004103A AP2374A (en) 2005-02-26 2006-02-21 Isoxazoline derivative and novel process for its preparation.

Country Status (29)

Country Link
US (1) US8044080B2 (ko)
EP (1) EP1851214B1 (ko)
JP (1) JP4961357B2 (ko)
KR (1) KR100774999B1 (ko)
CN (1) CN101128459B (ko)
AP (1) AP2374A (ko)
AR (1) AR055314A1 (ko)
AU (1) AU2006217293B2 (ko)
BR (1) BRPI0607330B1 (ko)
CA (1) CA2598347C (ko)
DK (1) DK1851214T3 (ko)
EA (1) EA013005B1 (ko)
ES (1) ES2394480T3 (ko)
HK (1) HK1111146A1 (ko)
IL (1) IL185226A0 (ko)
MA (1) MA29311B1 (ko)
MX (1) MX2007010338A (ko)
MY (1) MY149181A (ko)
NO (1) NO341347B1 (ko)
NZ (1) NZ560805A (ko)
PE (1) PE20061076A1 (ko)
PL (1) PL1851214T3 (ko)
PT (1) PT1851214E (ko)
SG (1) SG156689A1 (ko)
SI (1) SI1851214T1 (ko)
TW (1) TWI377205B (ko)
UA (1) UA94395C2 (ko)
WO (1) WO2006090997A1 (ko)
ZA (1) ZA200707202B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101299720B1 (ko) * 2006-08-16 2013-08-28 주식회사 엘지생명과학 3-아미노-5-플루오로-4-디알콕시펜탄산 에스테르의 새로운제조방법
KR20090099886A (ko) * 2008-03-18 2009-09-23 주식회사 엘지생명과학 캐스파제 저해제의 프로드럭
TW201011014A (en) * 2008-07-11 2010-03-16 Gilead Sciences Inc Method of treatment and pharmaceutical compositions
TW201012816A (en) * 2008-07-11 2010-04-01 Gilead Sciences Inc Method of treatment and pharmaceutical compositions
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP2900661B1 (en) * 2012-09-28 2016-10-26 Bayer CropScience AG Quinoline isoxazolin derivatives for plant disease control
JP2017095353A (ja) * 2014-03-27 2017-06-01 日本曹達株式会社 イソオキサゾリン−5−カルボキサミド化合物および有害生物防除剤
US11434212B2 (en) * 2017-01-23 2022-09-06 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Bicyclic compound as a caspase inhibitor
EP3939976B1 (en) * 2019-04-19 2024-05-01 Lg Chem, Ltd. Prodrug of caspase inhibitor
US20220227743A1 (en) * 2019-04-30 2022-07-21 Lg Chem, Ltd. Prodrug of caspase inhibitor
US20220226234A1 (en) * 2019-05-31 2022-07-21 Lg Chem, Ltd. Injectable composition containing prodrug of caspase inhibitors, and preparation method therefor
EP3970699A4 (en) 2019-05-31 2022-08-10 LG Chem, Ltd. COMPOSITION FOR CASPASE INHIBITOR PRODRUG INJECTION
MX2023000230A (es) * 2020-08-05 2023-02-09 Lg Chemical Ltd Uso de inhibidor de caspasa para aliviar o tratar osteoartritis.
JP2023551508A (ja) 2020-11-30 2023-12-08 エルジー・ケム・リミテッド カスパーゼ阻害剤を含有する注射用組成物及びその製造方法
WO2023132606A1 (ko) * 2022-01-04 2023-07-13 주식회사 이노보테라퓨틱스 캐스파제 저해제로서의 신규한 이소인돌리논 유도체 화합물
WO2023140582A1 (ko) * 2022-01-24 2023-07-27 주식회사 엘지화학 이소옥사졸린 유도체를 포함하는 주사용 제제
KR20230126654A (ko) 2022-02-23 2023-08-30 주식회사 엘지화학 이소옥사졸린 유도체를 포함하는 주사용 제제 및 이의 제조방법
KR20230141971A (ko) 2022-03-24 2023-10-10 주식회사 엘지화학 이소옥사졸린 유도체를 포함하는 주사용 제제 및 이의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021600A1 (en) * 1999-09-17 2001-03-29 Lg Chem Investment Ltd. Caspase inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373375B1 (ko) * 1998-04-03 2003-06-12 주식회사 엘지생명과학 인터루킨-1b-컨버팅효소및아포파인/cpp-32에대한저해제
KR19990079267A (ko) 1998-04-03 1999-11-05 성재갑 이소옥사졸(또는 이소옥사졸린) 구조를 갖는 파네실 전이효소억제제
AU5762899A (en) 1999-09-17 2001-04-24 Lg Chemical Ltd. Caspase inhibitor
TWI256952B (en) * 2003-08-27 2006-06-21 Sk Corp Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
KR100594544B1 (ko) 2003-08-27 2006-06-30 주식회사 엘지생명과학 이소옥사졸린 구조를 갖는 캐스파제 저해제

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021600A1 (en) * 1999-09-17 2001-03-29 Lg Chem Investment Ltd. Caspase inhibitor

Also Published As

Publication number Publication date
EA200701810A1 (ru) 2008-02-28
EP1851214B1 (en) 2012-09-05
PL1851214T3 (pl) 2013-03-29
CN101128459B (zh) 2011-10-05
ES2394480T3 (es) 2013-02-01
NO341347B1 (no) 2017-10-16
WO2006090997A1 (en) 2006-08-31
AU2006217293B2 (en) 2012-02-02
MY149181A (en) 2013-07-31
IL185226A0 (en) 2008-02-09
ZA200707202B (en) 2008-10-29
DK1851214T3 (da) 2012-10-15
JP2008531551A (ja) 2008-08-14
SG156689A1 (en) 2009-11-26
EP1851214A1 (en) 2007-11-07
US20080262032A1 (en) 2008-10-23
UA94395C2 (ru) 2011-05-10
TWI377205B (en) 2012-11-21
TW200640918A (en) 2006-12-01
MA29311B1 (fr) 2008-03-03
BRPI0607330A2 (pt) 2009-09-29
CA2598347C (en) 2011-08-02
NZ560805A (en) 2010-12-24
NO20074895L (no) 2007-11-26
US8044080B2 (en) 2011-10-25
HK1111146A1 (en) 2008-08-01
CN101128459A (zh) 2008-02-20
KR100774999B1 (ko) 2007-11-09
BRPI0607330B1 (pt) 2021-08-03
SI1851214T1 (sl) 2012-11-30
KR20060094868A (ko) 2006-08-30
PE20061076A1 (es) 2006-12-27
AR055314A1 (es) 2007-08-15
EA013005B1 (ru) 2010-02-26
MX2007010338A (es) 2007-10-11
JP4961357B2 (ja) 2012-06-27
CA2598347A1 (en) 2006-08-31
AU2006217293A1 (en) 2006-08-31
EP1851214A4 (en) 2009-10-28
PT1851214E (pt) 2012-10-18

Similar Documents

Publication Publication Date Title
AP2374A (en) Isoxazoline derivative and novel process for its preparation.
EP1937766A4 (en) MODIFIED POLYAMIDES, USES THEREOF AND MANUFACTURING METHOD THEREFOR
GB0513866D0 (en) Process
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
GB0511460D0 (en) Process
GB0501730D0 (en) Process
IL190221A0 (en) Isoxazole derivatives
GB0506788D0 (en) Process
GB0500604D0 (en) Novel process
GB0519758D0 (en) Novel process
EP1907468A4 (en) METHOD FOR PRODUCING NANOVER FIBERS AND NANOVER BASED MATERIALS
GB0513978D0 (en) Process
GB0526474D0 (en) Novel process
GB0503694D0 (en) Process
GB0501349D0 (en) Process
GB0501102D0 (en) Process
EP1915131A4 (en) PROCESS
GB0503528D0 (en) Process
GB0512662D0 (en) Process
EP1915380A4 (en) PROCESS FOR THE SYNTHESIS OF N, N'-DISUBSTITUTED OXABISPIDINES
GB0505200D0 (en) Process
GB0505221D0 (en) Process
GB0504079D0 (en) Process
GB0501254D0 (en) Process
GB0501100D0 (en) Process